Kazakhstan Medical Device Recall and Field Corrective Action: A Five-Link Handling Chain

1. Key takeaways

The handling chain for recalls and field corrective actions has five links: trigger (adverse events, sampling nonconformity, inspection findings, supplier changes, internal findings), then decision (whether to recall, the recall level, whether to notify the regulator), then notification (the regulatory authority, the authorized representative, distributors, medical institutions, users), then execution (collection, replacement, rework, on-site repair), and finally records and reporting (execution records, effectiveness evaluation, regulatory reports, closure). The link most easily overlooked is the fifth: execution is not closure. Missing effectiveness evaluation and closure records will be recorded as an unclosed loop at the next inspection, even if every affected unit has physically been recovered from the market. Building the five-link chain into a standing procedure, with owners and timelines for each link, is what converts this structure from a description into a working process.

2. Legal basis

3. Expert insights

Insight 1: corrective and preventive actions are one of the processes explicitly listed for evaluation under Decision No. 106. The inspection evaluates the effectiveness of the CAPA process itself, not merely the outcome of a single correction. This means that the execution records of recalls and field corrective actions become input material for the next inspection, so every recall file should be written as if an inspector will read it, because in practice one eventually will. Consistent formats across recalls also make trend analysis possible, which inspectors value.

Insight 2: every link in the notification chain must leave a record. Regulator, representative, distributor, medical institution, user: five categories of recipients, each with different notification methods and timelines. The approach of GRZAN is to build contact lists and notification templates in advance, then execute against the list item by item and record each notification when an event occurs, rather than searching for the right person while the clock is already running. The lists should be reviewed at fixed intervals, because distributor and institutional contacts change more often than most companies expect.

Insight 3: the notification chain in Kazakhstan must include the authorized representative. The representative is the liaison node between the regulatory authority and the company, and is also the entity named on the label and instructions for use. A recall notice that bypasses the representative creates an information gap between the regulator and the company, and that gap can turn a well-managed recall into a compliance finding on its own. The representative also needs the recall information to answer regulator questions, so notifying the representative first is usually the practical order. A short internal rule fixing this sequence removes any debate about ordering when an event lands at an inconvenient hour.

Insight 4: the unplanned inspection is the formal channel for restoring compliant status. Under Decision No. 106, a manufacturer may apply for an unplanned inspection for the purpose of confirming that the causes leading to nonconforming devices leaving the factory have been eliminated. After a major recall is completed, obtaining formal confirmation through this channel carries far more weight than closing the case internally, and it provides documented evidence for regulators and customers alike. The confirmation closes the loop on paper and removes the ambiguity that an internally closed recall always leaves behind.

Insight 5: the corrective action rules differ between the two pathways. The national pathway follows Order No. ҚР ДСМ-320/2020, while the Union pathway follows Decision No. 174. Where a portfolio combines both pathways, recall processes must be executed separately by pathway; a single template cannot cover all products, because the reporting content, the notification objects and the applicable timelines are defined by different instruments. Mapping each product to its pathway in the recall procedure avoids this ambiguity at the moment it matters most.

4. Practical recommendations

1. Build contact lists and notification templates for the five categories of recipients in advance, execute against the list and leave records when an event occurs.
2. Make sure the recall notification chain explicitly includes the authorized representative, keeping the information channel between regulator and company open.
3. After execution, perform an effectiveness evaluation and issue closure records; do not stop at the fact that goods have been recovered.
4. After a major recall, obtain formal confirmation through the unplanned inspection channel of Decision No. 106.
5. Design recall processes separately for the national pathway and the Union pathway instead of covering both with one template.

5. Verification checklist

• □ Contact lists and notification templates for the five categories of recipients have been built in advance
• □ The notification chain includes the authorized representative
• □ The time, method, recipient and content of every notification have been recorded
• □ After execution, an effectiveness evaluation has been completed and closure records issued
• □ Major recalls have obtained confirmation through the unplanned inspection of Decision No. 106
• □ Recall processes for the national pathway (Order No. 320/2020) and the Union pathway (Decision No. 174) have been designed separately

Regulatory information verified as of October 29, 2026.

GRZAN provides registration and post-market compliance support for medical device manufacturers, importers and authorized representatives in Kazakhstan, including recall management, field corrective actions and regulatory notification. For inquiries, contact info@grzanglobal.com.